Author

D. Myslivcova

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Obr· 1 shared H. Klamova· 1 shared J. Brezinova· 1 shared K. Cermakova· 1 shared M. Zackova· 1 shared O. Mitrovsky· 1 shared S. Ransdorfova· 1 shared T. Machackova-Lopotova· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Obr

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inhibition of Casein Kinase 2 induces cell death in chronic myelogenous leukemia cells resistant to tyrosine kinase inhibitors

O. Mitrovsky, D. Myslivcova, T. Machackova-Lopotova, A. Obr, K. Cermakova, S. Ransdorfova, J. Brezinova, H. Klamova, M. Zackova

This study shows that inhibiting Casein Kinase 2 (CK2) induces cell death in chronic myelogenous leukemia (CML) cells resistant to tyrosine kinase inhibitors (TKIs) and may enhance TKI efficacy.

bioRxiv · Jun 28, 2021Cancer Biology